Mn Services Vermogensbeheer B.V. Johnson & Johnson Transaction History

Mn Services Vermogensbeheer B.V.

$14.3 Billion
Q3 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Johnson & Johnson stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 931,385 shares of JNJ stock, worth $145 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

931,385

Previous 952,585 2.23%

Holding current value

$145 Million

Previous $139 Million 8.41%

% of portfolio

1.06%

Previous 1.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$145.48 - $167.38 $3.08 Million - $3.55 Million	-21,200 Reduced 2.23%	931,385 $151 Million
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $2.28 Million - $2.49 Million	-15,800 Reduced 1.63%	952,585 $139 Million
Q1 2024 Apr 29, 2024	BUY	$155.22 - $162.74 $12.5 Million - $13.1 Million	80,700 Added 9.09%	968,385 $153 Million
Q4 2023 Jan 29, 2024	SELL	$145.6 - $158.88 $3.39 Million - $3.7 Million	-23,300 Reduced 2.56%	887,685 $139 Million
Q3 2023 Oct 25, 2023	SELL	$155.75 - $174.48 $9.17 Million - $10.3 Million	-58,900 Reduced 6.07%	910,985 $142 Million
Q2 2023 Aug 09, 2023	BUY	$154.35 - $166.11 $21.4 Million - $23.1 Million	138,800 Added 16.7%	969,885 $161 Million
Q1 2023 Apr 26, 2023	BUY	$151.05 - $180.26 $4.29 Million - $5.12 Million	28,400 Added 3.54%	831,085 $129 Million
Q4 2022 Feb 03, 2023	SELL	$160.2 - $179.79 $20 Million - $22.4 Million	-124,600 Reduced 13.44%	802,685 $142 Million
Q3 2022 Nov 01, 2022	SELL	$161.33 - $179.52 $8.87 Million - $9.87 Million	-55,000 Reduced 5.6%	927,285 $151 Million
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $59.9 Million - $66.3 Million	-356,300 Reduced 26.62%	982,285 $174 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $14 Million - $15.9 Million	-88,600 Reduced 6.21%	1,338,585 $237 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $4.24 Million - $4.71 Million	27,200 Added 1.94%	1,427,185 $244 Million
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $3.94 Million - $4.38 Million	24,400 Added 1.77%	1,399,985 $226 Million
Q2 2021 Aug 05, 2021	BUY	$159.48 - $171.07 $19.1 Million - $20.5 Million	119,700 Added 9.53%	1,375,585 $191 Million
Q4 2020 Feb 09, 2021	BUY	$137.11 - $157.38 $2.15 Million - $2.47 Million	15,700 Added 1.27%	1,255,885 $198 Million
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $2.77 Million - $3.03 Million	19,700 Added 1.61%	1,240,185 $185 Million
Q2 2020 Jul 23, 2020	SELL	$128.81 - $155.51 $11.2 Million - $13.5 Million	-87,100 Reduced 6.66%	1,220,485 $172 Million
Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $9.25 Million - $12.8 Million	-83,200 Reduced 5.98%	1,307,585 $171 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $5.93 Million - $6.81 Million	46,500 Added 3.46%	1,390,785 $203 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $46.5 Million - $52 Million	365,989 Added 37.41%	1,344,285 $174 Million
Q2 2019 Jul 25, 2019	SELL	$131.15 - $144.24 $15.2 Million - $16.7 Million	-115,800 Reduced 10.58%	978,296 $136 Million
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $1.27 Million - $1.41 Million	10,100 Added 0.93%	1,094,096 $153 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $80.3 Million - $96.7 Million	654,085 Added 152.14%	1,083,996 $122 Million
Q3 2018 Nov 02, 2018	BUY	$121.58 - $142.88 $462,004 - $542,944	3,800 Added 0.89%	429,911 $59.4 Million
Q2 2018 Aug 13, 2018	BUY	$119.4 - $131.76 $214,920 - $237,167	1,800 Added 0.42%	426,111 $51.7 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $713,070 - $844,397	5,700 Added 1.36%	424,311 $54.4 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $3.48 Million - $3.81 Million	-26,500 Reduced 5.95%	418,611 $48.7 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $57.6 Million - $60.3 Million	445,111	445,111 $57.9 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Johnson & Johnson Transaction History